StockOtters
StockOttersSupply Chain Map
Sinopharm Group Co. Ltd. logo

Sinopharm Group Co. Ltd.

1099.HK

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
75,986
Cost of Revenue
70,233
Gross Profit
5,753
Gross Margin
7.6%
Operating Income
2,104
Operating Margin
2.8%
Net Income
916
Net Margin
1.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
2,623
EBITDA Margin
3.5%

2023

12/31/2023

Revenue
77,554
Cost of Revenue
71,248
Gross Profit
6,307
Gross Margin
8.1%
Operating Income
2,627
Operating Margin
3.4%
Net Income
1,177
Net Margin
1.5%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
3,497
EBITDA Margin
4.5%

2022

12/31/2022

Revenue
71,779
Cost of Revenue
65,613
Gross Profit
6,166
Gross Margin
8.6%
Operating Income
2,679
Operating Margin
3.7%
Net Income
1,108
Net Margin
1.5%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
3,412
EBITDA Margin
4.8%

2021

12/31/2021

Revenue
67,737
Cost of Revenue
62,010
Gross Profit
5,727
Gross Margin
8.5%
Operating Income
2,563
Operating Margin
3.8%
Net Income
1,009
Net Margin
1.5%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
3,209
EBITDA Margin
4.7%

2020

12/31/2020

Revenue
59,334
Cost of Revenue
54,092
Gross Profit
5,242
Gross Margin
8.8%
Operating Income
2,309
Operating Margin
3.9%
Net Income
934
Net Margin
1.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
2,941
EBITDA Margin
5.0%